Haematological Cancers

Trial AML 18
Cancer Type Haematological Cancers, Leukaemia, and Other Haematological
Hospital(s) Belfast City Hospital
Information

AML 18 A Trial For Older Patients With Acute Myeloid Leukaemia And High Risk Myelodysplastic Syndrome

Click Here to view CancerHelpUK trial summary
Trial AML19
Cancer Type Haematological Cancers and Leukaemia
Hospital(s) Belfast City Hospital
Information

Adults with Acute Leukaemia or High Risk Myelodysplastic Syndrome

Click Here to view CancerHelpUK trial summary
Trial ENABLE-NGS
Cancer Type Haematological Cancers and Other Haematological
Hospital(s) Belfast City Hospital
Information

Enabling diagnosis in chronic B-cell lymphoproliferative disorders using Next-Generation Sequencing

Trial ENRICH
Cancer Type Haematological Cancers and Lymphoma
Hospital(s) Belfast City Hospital
Information

A randomised, open label study of rituximab + ibrutinib (IR) vs rituximab + chemotherapy (R-Chemo) in older patients with untreated mantle cell lymphoma. Primary objective is to assess whether IR is superior to R-Chemo in terms of progression-free survival (PFS)

Trial Expanded PNH Registry
Cancer Type Haematological Cancers and Other Haematological
Hospital(s) Belfast City Hospital
Information

Paroxysmal Nocturnal Haemoglobinuria (PNH) Registry

Trial FLAIR
Cancer Type Haematological Cancers and Leukaemia
Hospital(s) Altnagelvin Hospital, Belfast City Hospital, and Craigavon Hospital
Information

Front-Line therapy in CLL: Assessment of Ibrutinib + Rituximab

Click Here to view CancerHelpUK trial summary
Trial Idiopathic Cytopenia
Cancer Type Haematological Cancers and Other Haematological
Hospital(s) Belfast City Hospital
Information

Improving diagnosis in idiopathic cytopenia using gene sequencing

Trial LI-1
Cancer Type Haematological Cancers
Hospital(s) Belfast City Hospital
Information

A Programme Of Development For Older Patients With Acute Myeloid Leukaemia And High Risk Myelodysplastic Syndrome

Click Here to view CancerHelpUK trial summary
Trial Manifest
Cancer Type Haematological Cancers and Other Haematological
Hospital(s) Belfast City Hospital
Information

A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET
Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients with Haematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 with and without Ruxolitinib in Patients with Myelofibrosis)

Trial MaPLe
Cancer Type Haematological Cancers and Lymphoma
Hospital(s) Antrim Hospital, Belfast City Hospital, and Ulster Hospital
Information

Molecular Profiling for Lymphoma Study

Click Here to view CancerHelpUK trial summary
Trial TREATT
Cancer Type Haematological Cancers and Other Haematological
Hospital(s) Belfast City Hospital
Information

Trial To Evaluate Tranexamic Acid Therapy In Thrombocytopenia. A Double Blind, Randomised Controlled Trial Evaluating The Safety And Efficacy Of Tranexamic Acid In Patients With Haematological Malignancies With Severe Thrombocytopenia

Click Here to view CancerHelpUK trial summary
Trial UKALL 14
Cancer Type Haematological Cancers and Leukaemia
Hospital(s) Belfast City Hospital
Information

A randomised trial for adults with newly diagnosed acute lymphoblastic leukaemia

Click Here to view CancerHelpUK trial summary
Trial UKALL 2011
Cancer Type Children’s Cancer, Haematological Cancers, Leukaemia, and Lymphoma
Hospital(s) Belfast City Hospital and Royal Belfast Hospital for Sick Children
Information

United Kingdom National Randomised Trial for Children and Young Adults with Acute Lymphoblastic Leukaemia and Lymphoma 2011

Click Here to view CancerHelpUK trial summary